Cargando…

Impact of Epithelial–Mesenchymal Transition on the Immune Landscape in Breast Cancer

SIMPLE SUMMARY: The process of epithelial–mesenchymal transition (EMT) is thought to influence breast cancer tumor progression by affecting both tumor cells and the tumor microenvironment (TME). We aimed to study the impact of EMT-related markers on a breast cancer cohort and specifically analyze th...

Descripción completa

Detalles Bibliográficos
Autores principales: Khadri, Fatima-Zohra, Issac, Marianne Samir Makboul, Gaboury, Louis Arthur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533811/
https://www.ncbi.nlm.nih.gov/pubmed/34680248
http://dx.doi.org/10.3390/cancers13205099
_version_ 1784587403462180864
author Khadri, Fatima-Zohra
Issac, Marianne Samir Makboul
Gaboury, Louis Arthur
author_facet Khadri, Fatima-Zohra
Issac, Marianne Samir Makboul
Gaboury, Louis Arthur
author_sort Khadri, Fatima-Zohra
collection PubMed
description SIMPLE SUMMARY: The process of epithelial–mesenchymal transition (EMT) is thought to influence breast cancer tumor progression by affecting both tumor cells and the tumor microenvironment (TME). We aimed to study the impact of EMT-related markers on a breast cancer cohort and specifically analyze the involvement of Snail, Twist, ZEB1, N-cadherin, Vimentin, GRHL2, E-cadherin, and EpCAM and their respective outcome on both immune infiltration of the TME and clinicopathological features. The inflammatory infiltrate was more often associated with poorly differentiated carcinomas including triple-negative breast cancer (TNBC). The altered pattern of protein expression of epithelial markers markedly influenced the magnitude of the inflammatory infiltrate found in the TME. Overall, our data highlight the potential beneficial association of the EMT signature with the immune inflammatory response. This may open new avenues for rational decision making in the clinical use of immunotherapy in subsets of breast cancer patients, specifically TNBC. ABSTRACT: The impact of epithelial–mesenchymal transition (EMT) signature on the immune infiltrate present in the breast cancer tumor microenvironment (TME) is still poorly understood. Since there is mounting interest in the use of immunotherapy for the treatment of subsets of breast cancer patients, it is of major importance to understand the fundamental tumor characteristics which dictate the inter-tumor heterogeneity in immune landscapes. We aimed to assess the impact of EMT-related markers on the nature and magnitude of the inflammatory infiltrate present in breast cancer TME and their association with the clinicopathological parameters. Tissue microarrays were constructed from 144 formalin-fixed paraffin-embedded invasive breast cancer tumor samples. The protein expression patterns of Snail, Twist, ZEB1, N-cadherin, Vimentin, GRHL2, E-cadherin, and EpCAM were examined by immunohistochemistry (IHC). The inflammatory infiltrate in the TME was assessed semi-quantitatively on hematoxylin and eosin (H&E)-stained whole sections and was characterized using IHC. The inflammatory infiltrate was more intense in poorly differentiated carcinomas and triple-negative carcinomas in which the expression of E-cadherin and GRHL2 was reduced, while EpCAM was overexpressed. Most EMT-related markers correlated with plasma cell infiltration of the TME. Taken together, our findings reveal that the EMT signature might impact the immune response in the TME.
format Online
Article
Text
id pubmed-8533811
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85338112021-10-23 Impact of Epithelial–Mesenchymal Transition on the Immune Landscape in Breast Cancer Khadri, Fatima-Zohra Issac, Marianne Samir Makboul Gaboury, Louis Arthur Cancers (Basel) Article SIMPLE SUMMARY: The process of epithelial–mesenchymal transition (EMT) is thought to influence breast cancer tumor progression by affecting both tumor cells and the tumor microenvironment (TME). We aimed to study the impact of EMT-related markers on a breast cancer cohort and specifically analyze the involvement of Snail, Twist, ZEB1, N-cadherin, Vimentin, GRHL2, E-cadherin, and EpCAM and their respective outcome on both immune infiltration of the TME and clinicopathological features. The inflammatory infiltrate was more often associated with poorly differentiated carcinomas including triple-negative breast cancer (TNBC). The altered pattern of protein expression of epithelial markers markedly influenced the magnitude of the inflammatory infiltrate found in the TME. Overall, our data highlight the potential beneficial association of the EMT signature with the immune inflammatory response. This may open new avenues for rational decision making in the clinical use of immunotherapy in subsets of breast cancer patients, specifically TNBC. ABSTRACT: The impact of epithelial–mesenchymal transition (EMT) signature on the immune infiltrate present in the breast cancer tumor microenvironment (TME) is still poorly understood. Since there is mounting interest in the use of immunotherapy for the treatment of subsets of breast cancer patients, it is of major importance to understand the fundamental tumor characteristics which dictate the inter-tumor heterogeneity in immune landscapes. We aimed to assess the impact of EMT-related markers on the nature and magnitude of the inflammatory infiltrate present in breast cancer TME and their association with the clinicopathological parameters. Tissue microarrays were constructed from 144 formalin-fixed paraffin-embedded invasive breast cancer tumor samples. The protein expression patterns of Snail, Twist, ZEB1, N-cadherin, Vimentin, GRHL2, E-cadherin, and EpCAM were examined by immunohistochemistry (IHC). The inflammatory infiltrate in the TME was assessed semi-quantitatively on hematoxylin and eosin (H&E)-stained whole sections and was characterized using IHC. The inflammatory infiltrate was more intense in poorly differentiated carcinomas and triple-negative carcinomas in which the expression of E-cadherin and GRHL2 was reduced, while EpCAM was overexpressed. Most EMT-related markers correlated with plasma cell infiltration of the TME. Taken together, our findings reveal that the EMT signature might impact the immune response in the TME. MDPI 2021-10-12 /pmc/articles/PMC8533811/ /pubmed/34680248 http://dx.doi.org/10.3390/cancers13205099 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Khadri, Fatima-Zohra
Issac, Marianne Samir Makboul
Gaboury, Louis Arthur
Impact of Epithelial–Mesenchymal Transition on the Immune Landscape in Breast Cancer
title Impact of Epithelial–Mesenchymal Transition on the Immune Landscape in Breast Cancer
title_full Impact of Epithelial–Mesenchymal Transition on the Immune Landscape in Breast Cancer
title_fullStr Impact of Epithelial–Mesenchymal Transition on the Immune Landscape in Breast Cancer
title_full_unstemmed Impact of Epithelial–Mesenchymal Transition on the Immune Landscape in Breast Cancer
title_short Impact of Epithelial–Mesenchymal Transition on the Immune Landscape in Breast Cancer
title_sort impact of epithelial–mesenchymal transition on the immune landscape in breast cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533811/
https://www.ncbi.nlm.nih.gov/pubmed/34680248
http://dx.doi.org/10.3390/cancers13205099
work_keys_str_mv AT khadrifatimazohra impactofepithelialmesenchymaltransitionontheimmunelandscapeinbreastcancer
AT issacmariannesamirmakboul impactofepithelialmesenchymaltransitionontheimmunelandscapeinbreastcancer
AT gabourylouisarthur impactofepithelialmesenchymaltransitionontheimmunelandscapeinbreastcancer